Company News, Regulations

FDA on CBD

More questions than answers during hearing.

Author Image

By: TOM BRANNA

Editor

If you thought the FDA would have a productive, consequential hearing regarding cannabis and cannabidiol-based products, you must be smoking something. The US Food and Drug Administration's first hearing on cannabis and its nonintoxicating ingredient CBD took place on May 31, with more than 100 speakers offering views, including researchers, health professionals, advocates, manufacturers and opponents. The hearing came after hemp was legalized in the 2018 Farm Bill, leading to a crop of hem...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters